{"DataElement":{"publicId":"6955743","version":"1","preferredName":"Immunotherapeutic Agent Related Adverse Event Present Type","preferredDefinition":"Information related to the type of immunotherapeutic agent related adverse event that is present.","longName":"6955288v1.0:6955303v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"6955288","version":"1","preferredName":"Immunotherapeutic Agent Relationship Adverse Event Present","preferredDefinition":"Any substance that induces, enhances, restores or suppresses the host's immune system, or an agent that utilizes or is derived from a component of the immune system._A state of connectedness between people, objects, or events; to be associated or connected with something._Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._Being or existing in a specified place or at the specified time.","longName":"6955286v1.0:2233878v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"6955286","version":"1","preferredName":"Immunotherapeutic Agent Relationship Adverse Event","preferredDefinition":"Any substance that induces, enhances, restores or suppresses the host's immune system, or an agent that utilizes or is derived from a component of the immune system.:A state of connectedness between people, objects, or events; to be associated or connected with something.:Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","longName":"C308:C25648:C41331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapeutic Agent","conceptCode":"C308","definition":"Any substance that induces, enhances, restores or suppresses the host's immune system, or an agent that utilizes or is derived from a component of the immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Relationship","conceptCode":"C25648","definition":"A state of connectedness between people, objects, or events; to be associated or connected with something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93EC8B94-DB7D-03ED-E053-F662850AFC99","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93EC8B94-DB8B-03ED-E053-F662850AFC99","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"MORENOC","dateModified":"2020-03-05","changeDescription":"3/5/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6955303","version":"1","preferredName":"Immunotherapeutic Related Adverse Event Type","preferredDefinition":"The type of immunotherapeutic related adverse event.","longName":"6955303v1.0","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Hyperprogression","valueDescription":"Hyperprogression","ValueMeaning":{"publicId":"6973536","version":"1","preferredName":"Hyperprogression","longName":"6973536","preferredDefinition":"Paradoxical acceleration of tumor progression following the initiation of therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperprogression","conceptCode":"C165207","definition":"Paradoxical acceleration of tumor progression following the initiation of therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9464457E-8B29-42EE-E053-F662850A70DD","latestVersionIndicator":"Yes","beginDate":"2019-10-08","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-08","modifiedBy":"ONEDATA","dateModified":"2019-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9464457E-8B42-42EE-E053-F662850A70DD","beginDate":"2019-10-08","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-08","modifiedBy":"ONEDATA","dateModified":"2019-10-08","deletedIndicator":"No"},{"value":"Myocarditis","valueDescription":"Myocarditis","ValueMeaning":{"publicId":"2946008","version":"1","preferredName":"Myocarditis","longName":"2946008","preferredDefinition":"Inflammation of the muscle tissue of the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myocarditis","conceptCode":"C34831","definition":"Inflammation of the muscle tissue of the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746944AF-42A3-DCDB-E040-BB89AD437B02","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93EF8C2E-C8CD-238D-E053-F662850A85EC","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Colitis","valueDescription":"Colitis","ValueMeaning":{"publicId":"2684803","version":"1","preferredName":"Colitis","longName":"2684803","preferredDefinition":"Inflammation of the colon.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colitis","conceptCode":"C26723","definition":"Inflammation of the colon.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B0AABC6-5698-5AC2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-09-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93EF8C2E-C8D7-238D-E053-F662850A85EC","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Hepatitis","valueDescription":"Hepatitis","ValueMeaning":{"publicId":"3257061","version":"1","preferredName":"Hepatitis","longName":"3257061","preferredDefinition":"Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis","conceptCode":"C3095","definition":"Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8AA35B8-AD6E-E3A8-E040-BB89AD43122A","latestVersionIndicator":"Yes","beginDate":"2011-07-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93EF8C2E-C8E1-238D-E053-F662850A85EC","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Nephritis","valueDescription":"Nephritis","ValueMeaning":{"publicId":"2581551","version":"1","preferredName":"Nephritis","longName":"2581551v1.00","preferredDefinition":"Inflammation of renal tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nephritis","conceptCode":"C26833","definition":"Inflammation of renal tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B9C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93EF8C2E-C8EB-238D-E053-F662850A85EC","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Myositis","valueDescription":"Myositis","ValueMeaning":{"publicId":"2562650","version":"1","preferredName":"Myositis","longName":"2562650","preferredDefinition":"An inflammatory process affecting the skeletal muscles. Causes include infections, injuries, and autoimmune disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myositis","conceptCode":"C27578","definition":"An inflammatory process affecting the skeletal muscles. Causes include infections, injuries, and autoimmune disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1C7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93EF8C2E-C8F5-238D-E053-F662850A85EC","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Pneumonitis","valueDescription":"Pneumonitis","ValueMeaning":{"publicId":"6063466","version":"1","preferredName":"Pneumonitis","longName":"6063466","preferredDefinition":"A disorder characterized by inflammation focally or diffusely affecting the lung parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pneumonitis, CTCAE","conceptCode":"C143767","definition":"A disorder characterized by inflammation focally or diffusely affecting the lung parenchyma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64948057-08D8-1045-E053-F662850AD8CF","latestVersionIndicator":"Yes","beginDate":"2018-02-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-06","modifiedBy":"MAESKEB","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93EF8C2E-C8FF-238D-E053-F662850A85EC","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Meningitis/Encephalitis","valueDescription":"Meningitis Encephalitis","ValueMeaning":{"publicId":"6955304","version":"1","preferredName":"Meningitis Encephalitis","longName":"6955304","preferredDefinition":"A disorder characterized by acute inflammation of the meninges of the brain and/or spinal cord.: Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Meningitis","conceptCode":"C26828","definition":"A disorder characterized by acute inflammation of the meninges of the brain and/or spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Encephalitis","conceptCode":"C26760","definition":"An inflammatory process affecting the brain parenchyma. Causes include viral infections and less frequently bacterial infections, toxins, and immune-mediated processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93EF8C2E-C90C-238D-E053-F662850A85EC","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93EF8C2E-C925-238D-E053-F662850A85EC","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Dermatitis","valueDescription":"Dermatitis","ValueMeaning":{"publicId":"3210810","version":"1","preferredName":"Dermatitis","longName":"3210810","preferredDefinition":"An inflammatory process affecting the skin. Signs include red rash, itching, and blister formation. Representative examples are contact dermatitis, atopic dermatitis, and seborrheic dermatitis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dermatitis","conceptCode":"C2983","definition":"An inflammatory process affecting the skin. Signs include red rash, itching, and blister formation. Representative examples are contact dermatitis, atopic dermatitis, and seborrheic dermatitis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A3C2-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93EF8C2E-C92F-238D-E053-F662850A85EC","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Endocrinopathies","valueDescription":"Endocrine Disorder","ValueMeaning":{"publicId":"2578544","version":"1","preferredName":"Endocrine Disorder","longName":"2578544","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the endocrine system. Representative examples of non-neoplastic disorders include diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency. Representative examples of neoplastic disorders include carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endocrine System Disorder","conceptCode":"C3009","definition":"A non-neoplastic or neoplastic disorder that affects the endocrine system. Representative examples of non-neoplastic disorders include diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency. Representative examples of neoplastic disorders include carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FFDD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-05","modifiedBy":"HARTLEYG","dateModified":"2019-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93EF8C2E-C943-238D-E053-F662850A85EC","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Neuropathy","valueDescription":"Neuropathy","ValueMeaning":{"publicId":"2751427","version":"1","preferredName":"Neuropathy","longName":"2751427","preferredDefinition":"A disorder affecting the cranial nerves or the peripheral nervous system.  It is manifested with pain, tingling, numbness, and muscle weakness.  It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuropathy","conceptCode":"C4731","definition":"A disorder affecting the cranial nerves or the peripheral nervous system. It manifests with pain, tingling, numbness, and muscle weakness. It may be the result of physical injury, toxic substances, viral diseases, diabetes, renal failure, cancer, and drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DC8C1F0-9010-1819-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93EF8C2E-C94D-238D-E053-F662850A85EC","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Rheumatological conditions","valueDescription":"Rheumatologic Disorder","ValueMeaning":{"publicId":"2971319","version":"1","preferredName":"Rheumatologic Disorder","longName":"2971319","preferredDefinition":"Inflammatory and degenerative diseases of connective tissue structures, such as arthritis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rheumatologic Disorder","conceptCode":"C27204","definition":"Inflammatory and degenerative diseases of connective tissue structures, such as arthritis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B198A4F-6835-7611-E040-BB89AD430A1F","latestVersionIndicator":"Yes","beginDate":"2009-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-19","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93EF8C2E-C961-238D-E053-F662850A85EC","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Rare Infections","valueDescription":"Infrequent Infection","ValueMeaning":{"publicId":"6955305","version":"1","preferredName":"Infrequent Infection","longName":"6955305","preferredDefinition":"Not occurring regularly or at short intervals.: The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infrequent","conceptCode":"C64954","definition":"Not occurring regularly or at short intervals.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Infection","conceptCode":"C128320","definition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93EF8C2E-C96E-238D-E053-F662850A85EC","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93EF8C2E-C987-238D-E053-F662850A85EC","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93EF8C2E-C991-238D-E053-F662850A85EC","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"ONEDATA","dateModified":"2019-10-02","deletedIndicator":"No"},{"value":"Hematologic cytopenias","valueDescription":"Hematologic Cytopenia","ValueMeaning":{"publicId":"7245657","version":"1","preferredName":"Hematologic Cytopenia","longName":"7245657","preferredDefinition":"Pertaining to or related to the blood and blood-forming organs.: A condition in which there is a lower-than-normal number of blood cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematologic","conceptCode":"C62780","definition":"Pertaining to or related to the blood and blood-forming organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cytopenia","conceptCode":"C2979","definition":"A laboratory test result indicating an abnormally low quantity of circulating blood cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A33E21D5-1654-4514-E053-F662850A7220","latestVersionIndicator":"Yes","beginDate":"2020-04-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-14","modifiedBy":"ONEDATA","dateModified":"2020-04-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A33E21D5-166D-4514-E053-F662850A7220","beginDate":"2020-04-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-14","modifiedBy":"ONEDATA","dateModified":"2020-04-14","deletedIndicator":"No"},{"value":"Infections of interest","valueDescription":"Infection Interest","ValueMeaning":{"publicId":"7245656","version":"1","preferredName":"Infection Interest","longName":"7245656","preferredDefinition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.: A state of curiosity or concern about or attention to something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infection","conceptCode":"C128320","definition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interest","conceptCode":"C60730","definition":"A state of curiosity or concern about or attention to something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A33FBFC7-D460-3237-E053-F662850AF90F","latestVersionIndicator":"Yes","beginDate":"2020-04-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-14","modifiedBy":"ONEDATA","dateModified":"2020-04-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A33FBFC7-D479-3237-E053-F662850AF90F","beginDate":"2020-04-14","endDate":null,"createdBy":"MORENOC","dateCreated":"2020-04-14","modifiedBy":"ONEDATA","dateModified":"2020-04-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93EF8C2E-C8B7-238D-E053-F662850A85EC","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"MORENOC","dateModified":"2020-04-14","changeDescription":"3/5/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Which of the following irAEs","type":"Preferred Question Text","description":"Which of the following irAEs are present at the time of registration?","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93F06996-5936-2379-E053-F662850A939C","latestVersionIndicator":"Yes","beginDate":"2019-10-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-10-02","modifiedBy":"MORENOC","dateModified":"2020-03-05","changeDescription":"3/5/2020: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}